This directory serves as a resource listing of active biotech that develop therapeutics, diagnostics and/or medtech. The companies listed in this directory are not representative of the companies that are active members of the Biotech and Money community.
Add / Amend your company listing for free
(only active biotech ie. therapeutic, diagnostic and medtech companies are eligible for listing)
USA
13therapeutics is a research and drug development company identifying and characterizing novel anti-inflammatory peptide therapeutics for unmet medical needs with high commercial potential. P13 is the company's most advanced peptide and is being tested for treatment of Acute Otitis Media (AOM) and other inflammatory conditions. Other peptides are under evaluation for a variety of autoimmune and inflammatory diseases.
1molar inc. is a biomedical technology company focused on neural regeneration after spinal cord injury and ischemic stroke. It strives to impact lives through the discovery, development, commercialization, and manufacturing of novel therapeutics on this area. The company leverages its expertise in neuroscience, synthetic biology and tissue engineering to produce product candidates designed to stimulate regeneration.
3-V Biosciences is a biopharmaceutical company focused on discovering and developing novel therapeutics that modulate key pathways for the treatment of oncology and infectious disease.
4P Therapeutics is a company conducting research and development of novel transdermal drug delivery technologies and products. They work with their partners to develop transdermal products with formulations of small and large molecules including biologics. Their world leading experience in this focused area allows them to efficiently evaluate and utilize the appropriate transdermal technology for a particular drug formulation. They are not a one technology platform company but create product IP from combinations of known technologies such as microneedles and microporation and new formulations of drugs. They conduct preclinical and early stage clinical studies at our company headquarters in Norcross (Atlanta) Georgia. Their model allows their partners to get key proof of concept data efficiently and effectively (low cost short timeline) and mitigate significant risk before the necessary higher development spend.
A&G Pharmaceutical discovers, develops, and commercializes innovative personalized medicine products that improve screening, monitoring, and targeted treatment of cancer and other human diseases. Company's lead drug/test products in development target breast cancer based on a unique biomarker known as GP88, or progranulin (GP88/PGRN), which is produced by breast cancer tumors and is used to help the cancer grow and proliferate.
A&G Pharmaceutical is a theranostics company creating and developing monoclonal antibodies to cancer-specific targets as a basis for novel therapeutic and diagnostic products. The company is currently advancing a near-term opportunity to develop and commercialize a line of diagnostic test kits that will improve early detection, diagnosis, and treatment of breast cancer based on GP88, a patented and proprietary growth factor discovered by A&G researchers.
A.P. Pharma is a specialty pharmaceutical company developing products using its proprietary Biochronomer? polymer-based drug delivery platform. This drug delivery platform is designed to improve the therapeutic profile of injectable pharmaceuticals by converting them from products that must be injected once or twice per day to products that need to be injected only once every one or two weeks. The Company's lead product candidate, APF530, is being developed for the prevention of both acute- and delayed-onset chemotherapy-induced nausea and vomiting.
Aastrom Biosciences is dedicated to the development of stem cell treatments for critical cardiovascular diseases. Aastrom is currently evaluating its autologous cellular therapies in US clinical trials in the treatment of dilated cardiomyopathy (DCM).
Abeille Pharmaceuticals, Inc. operates as a pharmaceutical product development company. Company?s initial focus is on developing products in oncology supportive care and diabetes and related metabolic disorders, based on technologies such as transdermal delivery and oral controlled-release systems.
Abeome Corporation is a privately-held biotechnology company that discovers therapeutic and diagnostic monoclonal antibodies (mAbs) using their proprietary technology. Company makes custom mAbs under both fee-for-service and co-development agreements to serve academic and corporate partners around the world.
AbGenomics International Inc., incorporated in Delaware with principal office in San Francisco Bay Area, is a biopharmaceutical company with its R&D foundation established since June 2000. AbG is a clinical stage company integrated globally and virtually to develop antibody therapeutics and companion diagnostics for the treatment of cancer and immune related inflammatory diseases.
Abide Therapeutics develop innovative medicines that target serine hydrolases, one of the largest enzyme classes in nature with validated but mostly untapped therapeutic potential. Abide has created a proprietary platform, that specifically targets serine hydrolases with selective small molecules.